Crossmark

A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitors

Crossref DOI link: https://doi.org/10.1186/s42269-022-00874-1

Published Online: 2022-06-29

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ugbe, Fabian Audu http://orcid.org/0000-0001-7052-4959
Shallangwa, Gideon Adamu

Uzairu, Adamu

Abdulkadir, Ibrahim
License Information

Text and Data Mining valid from 2022-06-29

Version of Record valid from 2022-06-29
More Information

Article History

Received: 19 May 2022

Accepted: 18 June 2022

First Online: 29 June 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below